Market Research Future

Ischemic Heart Disease Market Is Expected to Reach USD 2.84 Billion by 2022

Middle-East and Africa Ischemic heart Disease market information, by Type (stable angina, unstable angina, myocardial infarction, and Others) by Diagnosis (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others), by Treatment type (Medications, Surgery, Lifestyle changes, and others) - Forecast to 2022

 

Pune, Maharashtra -- (SBWIRE) -- 04/20/2017 -- Market Research Future has a half cooked research report on Middle-East and Africa Ischemic heart disease Market. The market for Middle-East and Africa Ischemic heart disease is growing continuously and expected to grow at a CAGR of 3.1% from 2015 to 2022.

Test the market data and market information presented through more than 60 market data tables and figures spread over 55 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on "Middle-East and Africa Ischemic heart Disease Market Research Report - Forecast to 2022."

Market Highlights:
The Middle-East and Africa Ischemic heart disease Market has been evaluated as steadily growing market and it is expected that the market will continue to grow at same pace in the near future. Ischemic heart disease is condition that affects blood supply to the heart. Due to the deposition of cholesterol on their walls, the blood vessels are narrowed or blocked. Ischemic heart disease also known as a cancer that starts in the colon or the rectum. Colorectal cancers can also called Coronary artery disease. Risk factors include, smoking, diabetes, high blood pressure, obesity, lack of exercise, high blood cholesterol, unhealthy diet, and excessive alcohol, and others. Rising consumer awareness and continuous development of treatment for Ischemic heart disease are driving the growth for the Middle-East and Africa Ischemic heart disease market. Major drugs and device manufacturers are investing amount of money for R & D to find cure for Ischemic heart disease. Increasing spending for healthcare, developing infrastructure, and expanded insurance coverage are leading the growth for Middle-East and Africa Ischemic heart disease. Middle-East and Africa Ischemic heart disease Market was estimated around US$ 2.28 billion in 2015 and is expected to reach US$ 2.84 billion by 2022 at a CAGR of 3.1%. There are several factors which are prohibiting the growth of the market such as high cost of treatment and drugs, lack of early diagnosis, lack of awareness and healthcare facilities particularly in African countries etc.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2585

Key Players of Ischemic Heart Disease Market:
- King Faisal Specialist Hospital and Research Centre (Saudi Arabia)
- Riyadh Military Hospital (Saudi Arabia)
- Hamad Medical Corporation (Qatar)
- American Hospital Dubai
- Ganzouri Specialized Hospital (Egypt)
- AstraZeneca (U.K.)
- Sanofi (France)
- Merck Sharp & Dohme Corp. (U.S.)
- AUM Cardiovascular (US)
- HeartWare (U.S.)

Segmentation:
Middle-East and Africa Ischemic heart disease market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others. On the basis of diagnosis the market is segmented into Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others. On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others.

Regional Analysis:
Considering the Middle-East and Africa Ischemic heart Disease market scenario, UAE region is believed to be the largest market for Middle-East and Africa Ischemic heart Disease. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart Disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

Access Report Details @ https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Akash Anand
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com